Table of Contents   This Chapter   All Chapters

FURTHER READING

Berg G, et al. Cutaneous lymphomas. Dermatology 1997; 9: 137 - 204

Fretzin DF, Helwig EB. Atypical fibroxanthoma of the skin: a clinicopathologic study of 140 cases. Cancer 1973; 31: 1541 - 52

Fung MA, Murphy MJ, Hoss DM, et al. Practical evaluation and management of cutaneous lymphoma. J Am Acad Dermatol 2002; 46: 325 - 57

Gloster HM. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996; 35: 355 - 74

Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002; 20:588 - 98

Hitchcock CL, Bland KI, Laney RG, et al. Neuroendocrine (Merkel cell) carcinoma of the skin: its natural history, diagnosis and treatment. Ann Surg 1988;207:01 - 7

Kalinke DU, Dummer R, Burg G. Management of cutaneous T-cell lymphoma. Curr Opin Dermatol 1996; 3: 71 - 6

Krasagakis K, Almond-Roesler B, Zouboulis CC. Merkel cell carcinoma: report of ten cases with emphasis on clinical course, treatment, and in vitro drug sensitivity. J Am Acad Dermatol 1997; 36: 727 - 32

Miller SJ, Maloney ME. Cutaneous Oncology. Oxford : Blackwell Science, 1998

Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol 1995; 33:161 - 82

Whittaker SJ et al. Joint British Association of dermatologists and UK Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149: 1095 - 107

Wieselthier JS, Koh HK. Sézary syndrome: diagnosis, prognosis and critical review of treatment options. J Am Acad Dermatol 1990; 22: 381 - 401

Wood GS (ed). The diagnosis and treatment of cutaneous T-cell lymphoma. Dermatol Ther 2003; 16: 269 - 361

White/Cox: Diseases of the Skin, 2ed.(c) 2006, Elsevier Inc. All rights reserved.